Rigel Therapeutics expands oncology portfolio with REZLIDHIA & GAVRETO, sees promising R289 results. Click here to read my ...
After months of waiting, Galaxy S23, Galaxy S23 Plus, and Galaxy S23 Ultra users can try out One UI 7 through the beta program for unlocked phones in the US and India. Carrier-locked S23 phones ...
Almost a year to the day after Roche pulled out a partnership on its underperforming cancer therapy Gavreto, Blueprint Medicines has sold US commercial rights to the drug to Rigel Pharma in a deal ...
Rigel Chemicals Private Limited is an Indian Non-Government Company. It's a private company and is classified as'company limited by shares'. Company's authorized capital stands at Rs 5.0 lakhs and has ...
After hours: March 12 at 4:02:30 PM EDT Loading Chart for NRC ...